• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1804400-28
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Dyspnea (1816); Fatigue (1849); Thrombosis/Thrombus (4440)
Event Date 07/14/2022
Event Type  Injury  
Event Description
It was reported that the procedure was to treat the mid right coronary artery (rca) and the distal rca.The patient had two unspecified xience skypoint stents implanted in (b)(6) of 2022.A 2.5x15mm trek balloon dilatation catheter (bdc) was used to pre-dilate between the two stents.Slow deflation of the bdc was noted, but had no further issues and was removed successfully.Optical coherence tomography (oct) confirmed there was a gap between the two previously implanted stents and a 4.0x12mm xience skypoint stent was deployed successfully with slow deflation of the device noted; however, the stent delivery system was removed successfully.A 4.0x38mm xience skypoint stent was attempted to be implanted proximally from the previously implanted xience skypoint in january; however, failed to be implanted as interaction with the previously implanted stent was felt.The 3.5x20mm trek balloon dilatation catheter was advanced, then inflated twice to 12 and 10 atmospheres.The physician attempted three times to pull negative, but the bdc would not deflate.It was decided to remove the bdc with the entire system as one unit.During removal the shaft separated and became lodged in the elbow area.The separated portion was attempted to be removed via snare but was difficult.Therefore, an emboshield nav6 was advanced and used to capture the very distal portion of the balloon just enough to remove the balloon which remained inflated.There was no adverse patient sequela but clinically significant delay was noted.Both 2.5x15 and the 3.5x20mm trek balloons had too much contrast; however, amount is unknown.It was confirmed only one stent was previously implanted which was a 4.0x28mm xience skypoint on (b)(6) 2022.Thrombosis was noted and patient was experiencing angina, dyspnea and fatigue due to the thrombosis.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the information reviewed, there is no indication of a product quality issue.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined; however, the subsequent treatments appear to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.The reported patient effects of angina, dyspnea and thrombosis are listed in the xience skypoint, everolimus eluting coronary stent system (eecss), electronic instructions for use as known patient effects of coronary stenting procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling.The three additional devices referenced are filed under separate medwatch report numbers.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key15442239
MDR Text Key300092797
Report Number2024168-2022-09829
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648233500
UDI-Public08717648233500
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 09/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/28/2023
Device Model Number1804400-28
Device Catalogue Number1804400-28
Device Lot Number1062341
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/24/2022
Initial Date FDA Received09/16/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/29/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
3.5X20MM TREK; 4.00X38MM XIENCE SKYPOINT; 4.0X12MM XIENCE SKYPOINT
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age49 YR
Patient SexMale
Patient Weight131 KG
-
-